Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9297 |
High Similarity |
NPD1240 |
Approved |
0.9154 |
High Similarity |
NPD1607 |
Approved |
0.9015 |
High Similarity |
NPD1510 |
Phase 2 |
0.8815 |
High Similarity |
NPD1549 |
Phase 2 |
0.8741 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8741 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8667 |
High Similarity |
NPD1551 |
Phase 2 |
0.854 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8413 |
Intermediate Similarity |
NPD9545 |
Approved |
0.84 |
Intermediate Similarity |
NPD9493 |
Approved |
0.8394 |
Intermediate Similarity |
NPD2796 |
Approved |
0.831 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8286 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8239 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8231 |
Intermediate Similarity |
NPD9717 |
Approved |
0.8182 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8151 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8112 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8095 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.806 |
Intermediate Similarity |
NPD9494 |
Approved |
0.8045 |
Intermediate Similarity |
NPD1203 |
Approved |
0.8043 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8042 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8041 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8015 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7987 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7971 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7947 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7945 |
Intermediate Similarity |
NPD920 |
Approved |
0.7933 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7931 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7931 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7905 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7879 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7872 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7867 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7867 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7867 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7832 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7832 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7832 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7829 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.78 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD3750 |
Approved |
0.777 |
Intermediate Similarity |
NPD943 |
Approved |
0.7763 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.776 |
Intermediate Similarity |
NPD9266 |
Approved |
0.776 |
Intermediate Similarity |
NPD74 |
Approved |
0.7721 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.771 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7708 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD2344 |
Approved |
0.768 |
Intermediate Similarity |
NPD9263 |
Approved |
0.768 |
Intermediate Similarity |
NPD9267 |
Approved |
0.768 |
Intermediate Similarity |
NPD9264 |
Approved |
0.768 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7626 |
Intermediate Similarity |
NPD411 |
Approved |
0.7612 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7597 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7597 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7589 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7584 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7582 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7568 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7552 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7552 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD919 |
Approved |
0.7532 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7481 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7464 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7452 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7438 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7431 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7426 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7419 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7407 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7391 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7375 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7362 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.736 |
Intermediate Similarity |
NPD9261 |
Approved |
0.7346 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7346 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7346 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7343 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7301 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.728 |
Intermediate Similarity |
NPD846 |
Approved |
0.728 |
Intermediate Similarity |
NPD940 |
Approved |
0.7278 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7273 |
Intermediate Similarity |
NPD9281 |
Approved |
0.7266 |
Intermediate Similarity |
NPD1164 |
Approved |
0.726 |
Intermediate Similarity |
NPD6100 |
Approved |
0.726 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7259 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7256 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7254 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7234 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7222 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7212 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7206 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7194 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7192 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7188 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7174 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7164 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7133 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7083 |
Intermediate Similarity |
NPD520 |
Approved |
0.7075 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7073 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7071 |
Intermediate Similarity |
NPD1876 |
Approved |
0.707 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7054 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7048 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7034 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7034 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7032 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7021 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7014 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7014 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7 |
Intermediate Similarity |
NPD290 |
Approved |
0.6993 |
Remote Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.6986 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6986 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.698 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD17 |
Approved |
0.6954 |
Remote Similarity |
NPD7003 |
Approved |
0.6944 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6934 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6929 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6918 |
Remote Similarity |
NPD4288 |
Approved |
0.6918 |
Remote Similarity |
NPD2296 |
Approved |
0.6918 |
Remote Similarity |
NPD1613 |
Approved |
0.6918 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6886 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD4749 |
Approved |
0.6879 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6867 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6857 |
Remote Similarity |
NPD1535 |
Discovery |
0.6853 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD4626 |
Approved |
0.6835 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6831 |
Remote Similarity |
NPD1283 |
Approved |
0.6818 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6813 |
Remote Similarity |
NPD5353 |
Approved |
0.6806 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6803 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.68 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.68 |
Remote Similarity |
NPD5408 |
Approved |
0.68 |
Remote Similarity |
NPD5405 |
Approved |
0.68 |
Remote Similarity |
NPD5406 |
Approved |
0.68 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.68 |
Remote Similarity |
NPD5404 |
Approved |
0.6797 |
Remote Similarity |
NPD1242 |
Phase 1 |
0.6794 |
Remote Similarity |
NPD968 |
Approved |
0.6791 |
Remote Similarity |
NPD228 |
Approved |
0.6783 |
Remote Similarity |
NPD3266 |
Approved |
0.6783 |
Remote Similarity |
NPD3267 |
Approved |
0.6781 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6781 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6774 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6774 |
Remote Similarity |
NPD4661 |
Approved |
0.6774 |
Remote Similarity |
NPD4662 |
Approved |
0.6761 |
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.6761 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6755 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6752 |
Remote Similarity |
NPD1653 |
Approved |
0.675 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.675
|
Remote Similarity |
NPD5761 |
Phase 2 |